PREDICTING MAJOR ADVERSE CARDIAC EVENTS AND INFARCT SIZE USING ST-SEGMENT RESOLUTION AS A CONTINUOUS RATHER THAN A DICHOTOMOUS VARIABLE IN PATIENTS ACHIEVING THROMBOLYSIS IN MYOCARDIAL INFARCTION FLOW GRADE III AFTER PRIMARY PERCUTANEOUS CORONARY INTERVENTION FOR ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION  by Kuijt, Wichert J. et al.
A101.E943
JACC March 9, 2010
Volume 55, issue 10A
 MYOCARDIAL ISCHEMIA AND INFARCTION 
PREDICTING MAJOR ADVERSE CARDIAC EVENTS AND INFARCT SIZE USING ST-SEGMENT RESOLUTION 
AS A CONTINUOUS RATHER THAN A DICHOTOMOUS VARIABLE IN PATIENTS ACHIEVING THROMBOLYSIS 
IN MYOCARDIAL INFARCTION FLOW GRADE III AFTER PRIMARY PERCUTANEOUS CORONARY 
INTERVENTION FOR ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
ACC Poster Contributions
Georgia World Congress Center, Hall B5
Sunday, March 14, 2010, 9:30 a.m.-10:30 a.m.
Session Title: Acute Myocardial Infarction--Outcomes
Abstract Category: Acute Myocardial Infarction--Therapy
Presentation Number: 1044-268
Authors: Wichert J. Kuijt, Andrzej S. Kosinski, Niels J. Verouden, Joost D. Haeck, Matthew T. Roe, Cindy L. Green, Karel T. Koch, Ricardo Baeza, Dan 
Tzivoni, Robbert J. De Winter, Mitchell W. Krucoff, Duke Clinical Research Institute, Durham, NC
Background: ST-segment resolution (STR) has been consistently correlated with clinical outcomes and other biomarkers in ST-segment elevation 
myocardial infarction (STEMI) patients. The frequently used dichotomous STR (DSTR) has never been compared with STR as a continuous variable 
(CSTR) or investigated in patients achieving TIMI-3 flow after primary PCI. We investigated DSTR vs. CSTR as predictor of major adverse cardiac 
events (MACE) or final infarct size (IS) in a cohort undergoing primary PCI.
Methods: We analyzed all 238 patients from the CASTEMI study with primary PCI with available TIMI flow; day 5-7 99mTc-sestamibi IS; and 12-lead 
high fidelity digital Holter core lab D- and C-STR analysis. MACE was defined as 30 day mortality, re-myocardial infarction or congestive heart failure. 
DSTR was defined as >70% or <70% STR and CSTR as the % STR from prior peak ST level at 30 minutes after last contrast injection. DSTR and CSTR 
were compared in both univariable and multivariable logistic (MACE) and linear (IS) regression models.
Results: CSTR and DSTR each had significant univariable correlation with probability of MACE (Fig. 1A) and IS (Fig 1B) in TIMI-3 patients. CSTR was 
significantly more predictive for IS (p<0.001 vs. 0.28) and strongly trended towards significance MACE (p=0.099 vs. 0.48).
Conclusion: CSTR outperforms DSTR as a prognostic marker for IS and MACE in patients with STEMI and post-procedural TIMI-3 flow, providing a 
significantly more robust surrogate end point for predicting clinical outcome.
